Evidence map›Paper›PMID 32294118›Full record

ArticlePloS one2020

Identification of NUDT15 gene variants in Amazonian Amerindians and admixed individuals from northern Brazil.

Juliana Carla Gomes Rodrigues, Tatiane Piedade de Souza, Lucas Favacho Pastana, André Maurício Ribeiro Dos Santos, Marianne Rodrigues Fernandes, Pablo Pinto, Alayde Vieira Wanderley, Sandro José de Souza, José Eduardo Kroll, Adenilson Leão Pereira and 10 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Genomic insights on lung cancer risk: identifying new variants in Amazonian indigenous populations.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  3. Article
  4. Distribution ofFrontiers in pharmacology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Frontiers in pharmacology · 2024
    Article
  13. Variants ofGenes · 2023
    Article
  14. Molecular Profile of Variants inJournal of personalized medicine · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Pharmacogenomic Profile of Amazonian Amerindians.Journal of personalized medicine · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 2 institutions in 1 country.

Juliana Carla Gomes RodriguesNúcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém, Pará, Brazil.
Tatiane Piedade de SouzaNúcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém, Pará, Brazil.
Lucas Favacho PastanaNúcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém, Pará, Brazil.
André Maurício Ribeiro Dos SantosLaboratório de Genética Humana e Médica, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém, Pará, Brazil.
Marianne Rodrigues FernandesNúcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém, Pará, Brazil.ORCID 0000-0002-1396-3442
Pablo PintoNúcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém, Pará, Brazil.
Alayde Vieira WanderleyHospital Ophir Loyola, Departamento de Pediatria, Belém, Pará, Brazil.
Sandro José de SouzaBrain Institute, Universidade Federal do Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil.
José Eduardo KrollBrain Institute, Universidade Federal do Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil.ORCID 0000-0002-7657-9536
Adenilson Leão PereiraLaboratório de Genética Humana e Médica, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém, Pará, Brazil.
Leandro MagalhãesLaboratório de Genética Humana e Médica, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém, Pará, Brazil.
Laís Reis das MercêsLaboratório de Genética Humana e Médica, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém, Pará, Brazil.
Amanda Ferreira VidalLaboratório de Genética Humana e Médica, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém, Pará, Brazil.
Tatiana Vinasco-SandovalLaboratório de Genética Humana e Médica, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém, Pará, Brazil.
Giovanna Chaves CavalcanteLaboratório de Genética Humana e Médica, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém, Pará, Brazil.
João Farias GuerreiroLaboratório de Genética Humana e Médica, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém, Pará, Brazil.
Paulo Pimentel de AssumpçãoNúcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém, Pará, Brazil.
Ândrea Ribeiro-Dos-SantosNúcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém, Pará, Brazil.
Sidney SantosNúcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém, Pará, Brazil.
Ney Pereira Carneiro Dos SantosNúcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém, Pará, Brazil.
Universidade Federal do Pará · BRUniversidade Federal do Rio Grande do Norte · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe nudix hydrolase 15 (NUDT15) gene acts in the metabolism of thiopurine, by catabolizing its active metabolite thioguanosine triphosphate into its inactivated form, thioguanosine monophosphate. The frequency of alternative NUDT15 alleles, in particular those that cause a drastic loss of gene function, varies widely among geographically distinct populations. In the general population of northern Brazilian, high toxicity rates (65%) have been recorded in patients treated with the standard protocol for acute lymphoblastic leukemia, which involves thiopurine-based drugs. The present study characterized the molecular profile of the coding region of the NUDT15 gene in two groups, non-admixed Amerindians and admixed individuals from the Amazon region of northern Brazil.

methodsThe entire NUDT15 gene was sequenced in 64 Amerindians from 12 Amazonian groups and 82 admixed individuals from northern Brazil. The DNA was extracted using phenol-chloroform. The exome libraries were prepared using the Nextera Rapid Capture Exome (Illumina) and SureSelect Human All Exon V6 (Agilent) kits. The allelic variants were annotated in the ViVa® (Viewer of Variants) software.

resultsFour NUDT15 variants were identified: rs374594155, rs1272632214, rs147390019, andrs116855232. The variants rs1272632214 and rs116855232 were in complete linkage disequilibrium, and were assigned to the NUDT15*2 genotype. These variants had high frequencies in both our study populations in comparison with other populations catalogued in the 1000 Genomes database. We also identified the NUDT15*4 haplotype in our study populations, at frequencies similar to those reported in other populations from around the world.

conclusionOur findings indicate that Amerindian and admixed populations from northern Brazil have high frequencies of the NUDT15 haplotypes that alter the metabolism profile of thiopurines.

Indexed as

Antimetabolites, AntineoplasticBrazilHumansIndigenous PeoplesMercaptopurineNudix HydrolasesPolymorphism, Single NucleotidePrecursor Cell Lymphoblastic Leukemia-LymphomaPyrophosphatasesAntimetabolites, AntineoplasticMercaptopurineNudix HydrolasesNUDT15 protein, humanPyrophosphatases

Identifiers

PMID32294118
PMCPMC7159207
OpenAlexW3015819535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.